Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feedernews.google.com
Bcl-2 inhibitor - Google News
Get the latest updates from Bcl-2 inhibitor - Google News directly as they happen.
Follow now < 10 followers
Latest posts
Last updated almost 4 years ago
Zinc complex of 3,5-di-tert-butyl salicylate inhibits viability, migration, and invasion in triple-negative breast cancer cells | Scientific Reports - Nature.com
almost 4 years ago
Zinc complex of 3,5-di-tert-butyl salicylate inhibits viability, migration, and invasion in triple-negative...
Positive phase II data in Parkinson's from Anavex and Sage opens Barcelona conference - BioWorld Online
almost 4 years ago
Positive phase II data in Parkinson's from Anavex and Sage opens Barcelona...
Stand up to Cancer announces $1 million donat - EurekAlert
almost 4 years ago
Stand up to Cancer announces $1 million donat EurekAlert
Activating activators is strategy against apoptosis defectors - BioWorld Online
almost 4 years ago
Activating activators is strategy against apoptosis defectors BioWorld Online
UNITY BIOTECHNOLOGY, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K) - Marketscreener.com
almost 4 years ago
UNITY BIOTECHNOLOGY, INC. Management's Discussion and Analysis of Financial Condition and Results...
STAND UP TO CANCER ANNOUNCES $1 MILLION DONATION FROM ZENTALIS PHARMACEUTICALS TO FUND TARGETED CANCER THERAPY RESEARCH - StreetInsider.com
almost 4 years ago
STAND UP TO CANCER ANNOUNCES $1 MILLION DONATION FROM ZENTALIS PHARMACEUTICALS TO...
STAND UP TO CANCER ANNOUNCES $1 MILLION DONATION FROM ZENTALIS PHARMACEUTICALS TO FUND TARGETED CANCER THERAPY RESEARCH - PR Newswire
almost 4 years ago
STAND UP TO CANCER ANNOUNCES $1 MILLION DONATION FROM ZENTALIS PHARMACEUTICALS TO...
Ascentage Pharma Announces First Patient Dosed in China in the Pivotal Phase II Study of Lisaftoclax (APG-2575) in R/R CLL/SLL - Yahoo Finance
almost 4 years ago
Ascentage Pharma Announces First Patient Dosed in China in the Pivotal Phase...
Ascentage Pharma Announces First Patient Dosed in China in the Pivotal Phase II Study of Lisaftoclax (APG-2575) in R/R CLL/SLL - PR Newswire
almost 4 years ago
Ascentage Pharma Announces First Patient Dosed in China in the Pivotal Phase...
Exosomal miR-143-3p derived from follicular fluid promotes granulosa cell apoptosis by targeting BMPR1A in polycystic ovary syndrome | Scientific Reports - Nature.com
almost 4 years ago
Exosomal miR-143-3p derived from follicular fluid promotes granulosa cell apoptosis by targeting...
Optimizing the Treatment of CLL With Novel Therapies - OncLive
almost 4 years ago
Optimizing the Treatment of CLL With Novel Therapies OncLive
Mays Cancer Center researcher and SignalRx earn NCI business grants to develop drugs for first-in-human clinical trials - PR Web
almost 4 years ago
Mays Cancer Center researcher and SignalRx earn NCI business grants to develop...